Healthcare >> Analyst Interviews >> November 2, 2009
Pharmaceutical Companies & Health Care Reform Plans – Damien Conover – Morningstar
Damien Conover, CFA, is the Editor of Morningstar's Healthcare Observer as well as an Equities Strategist for Morningstar, Inc. He has been covering the health care industry for nearly a decade with a focus on pharmaceutical and biotechnology companies. Before joining Morningstar in 2007, he held Equity Analyst positions at Raymond James Financial Inc., Bank of Montreal and Tucker Anthony. Mr. Conover is a recognized authority in health care investing, appearing regularly on Bloomberg TV, CNBC and CNN. He holds a bachelor's and master's degrees in finance from the University of Wisconsin, where he was a member of the Applied Security Analysis Program. Profile
TWST: What is your focus in the pharmaceuticals space?
Mr. Conover: I primarily cover the large pharmaceutical companies in the US and Europe, as well as what some consider diversified pharmaceutical